Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia
- 4 April 2015
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 11 (8) , 994-1004
Abstract
Introduction: Down syndrome (DS) is associated with amyloid b (Ab) deposition.Methods: We characterized imaging measurements of regional fibrillar Ab burden, cerebral metabolic rate for glucose (rCMRgl), gray matter volumes (rGMVs), and age associations in 5 DS with dementia (DS/AD1), 12 DS without dementia (DS/AD2), and 9 normal controls (NCs).Results: There were significant group differences in mean standard uptake value ratios (SUVRs) for florbetapir with DS/AD1 having the highest, followed by DS/AD2, followed by NC. For [18F]‐fluorodeoxyglucose positron emission tomography, posterior cingulate rCMRgl in DS/AD1 was significantly reduced compared with DS/AD2 and NC. For volumetric magnetic resonance imaging (vMRI), hippocampal volumes were significantly reduced for the DS/AD1 compared with DS/AD2 and NC. Age‐related SUVR increases and rCMRgl reductions were greater in DS participants than in NCs.Discussion: DS is associated with fibrillar Ab, rCMRgl, and rGMV alterations in the dementia stage and before the presence of clinical decline. This study provides a foundation for the studies needed to inform treatment and prevention in DS.Keywords
Funding Information
- National Institute on Aging (5P30AG019610‐12)
- Avid Radiopharmaceuticals
- National Institute on Aging (R01AG031581)
- National Institute of Mental Health (R01MH057899)
- Banner Alzheimer’s Foundation
- American Association for Respiratory Care
- Arizona Department of Health Services (12‐10553)
This publication has 40 references indexed in Scilit:
- Characterizing the Preclinical Stages of Alzheimer's Disease and the Prospect of Presymptomatic InterventionJournal of Alzheimer’s Disease, 2012
- Positron Emission Tomography and Neuropathologic Estimates of Fibrillar Amyloid-β in a Patient With Down Syndrome and Alzheimer DiseaseArchives of Neurology, 2011
- Age‐related cortical grey matter reductions in non‐demented Down’s syndrome adults determined by MRI with voxel‐based morphometryBrain, 2004
- Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementiaProceedings of the National Academy of Sciences, 2003
- Relation of Corpus Callosum and Hippocampal Size to Age in Nondemented Adults With Down’s SyndromeAmerican Journal of Psychiatry, 2003
- A voxel-based morphometric study of nondemented adults with Down SyndromeNeuroImage, 2003
- Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer’s Disease Treatment StudiesAmerican Journal of Psychiatry, 2002
- Relation of Medial Temporal Lobe Volumes to Age and Memory Function in Nondemented Adults With Down’s Syndrome: Implications for the Prodromal Phase of Alzheimer’s DiseaseAmerican Journal of Psychiatry, 2002
- Whole Brain SegmentationNeuron, 2002
- Voxel-Based Morphometry—The MethodsNeuroImage, 2000